While theyre fundamentally similar medications, they differ slightly in their mechanism of action: Wegovy (semaglutide) is a GLP-1 agonist Zepbound (tirzepatide) is a dual agonist: GLP-1 + a glucose-dependent insulinotropic polypeptide (GIP) Both semaglutide and tirzepatide affect the hypothalamus and the hedonic eating centers, the brains center of appetite and cravings
The SELECT trial showed a 20% reduction in major cardiovascular events
Introduction In 2023, a team of Italian scientists Giustarini D, Milzani A, Dalle-Donne I, Rossi R published a detailed review in the journal Antioxidants
Additionally, exogenous Cys increased the tolerance of maize plants to Hg but also decreased Hg accumulation (Aysin et al., 2020)
Statistical analysis Statistical analyses were performed using SPSS (version 26
The program is temporary for now only slated to run until the end of 2027